Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Real-world care patterns and specialist encounters of patients with systemic autoimmune rheumatic disease-related interstitial lung disease in the United States: a retrospective administrative claims database analysis.
Journal: Rheumatology (Oxford, England)
Published: January 24, 2025
Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.
Journal: Journal of managed care & specialty pharmacy
Published: January 31, 2019
Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis.
Journal: Health technology assessment (Winchester, England)
Published: September 14, 2018
Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England.
Journal: PharmacoEconomics
Published: March 03, 2018
The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation.
Journal: Health technology assessment (Winchester, England)
Published: July 07, 2017
Complications of long and intermediate term venous catheters in cystic fibrosis patients: A multicenter study.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: March 07, 2017
Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 29, 2016
The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.
Journal: Health technology assessment (Winchester, England)
Published: February 25, 2016
Model-Based Cost-Utility Analysis of Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Treatment Induced Anaemia in the UK NHS.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Pneumocystis jerovecii pneumonia in a patient with untreated chronic lymphocytic leukaemia: a novel case and postulations concerning the mechanism.
Journal: BMJ case reports
Published: November 30, 2013
The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No.150 and part review of technology appraisal No. 118): a systematic review and economic model.
Journal: Health technology assessment (Winchester, England)
Published: April 04, 2013
Cost-effectiveness of cetuximab, cetuximab plus irinotecan, and panitumumab for third and further lines of treatment for KRAS wild-type patients with metastatic colorectal cancer.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: July 11, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026